Perioperative anesthetic management for resection of giant retroperitoneal tumors
Frontiers in Oncology · 01.07.2026 · 16
DOI: 10.3389/fonc.2026.1833254 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 01.07.2026. Verfasst von Xiaoxia Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
The aim of this study was to summarize perioperative anesthetic management in patients undergoing resection of giant retroperitoneal tumors and to provide a reference for clinical practice.
Methods
This retrospective study analyzed data from 10 patients who underwent elective resection of giant retroperitoneal tumors (maximum diameter ≥ 15 cm) at a single institution between January 2018 and December 2023. Demographic characteristics, tumor features, preoperative preparations, intraoperative hemodynamic data, fluid and blood product administration, and postoperative complications were collected and analyzed. Descriptive statistical methods were applied.
Results
The cohort included 1 male and 9 female patients, with median mean age of 56.5 year-old (range, 24–79 year-old). The median maximum tumor diameter was 33 cm (range, 22–50 cm). Preoperative multidisciplinary team consultations were conducted in 8 patients, and interventional vascular embolization was performed in 7 patients. All patients received general anesthesia with endotracheal intubation. Invasive arterial pressure monitoring was used in all patients, central venous pressure monitoring in 9, and FloTrac™/Vigileo monitoring in 6. The median operative duration was 260 minutes. The median intraoperative blood loss was 2,700 mL, and the median cumulative duration of hypotension was 32 minutes. Eight patients received blood transfusions (The median cumulative transfusion volume of red blood cells and plasma was 2,650 mL). Vasoactive agents were administered in all patients. Postoperative complications included nausea and vomiting (3 cases), atelectasis (2 cases), pleural effusion (2 cases), and surgical site infection (2 cases). No perioperative mortality occurred.
Conclusion
The principal anesthetic challenges during resection of giant retroperitoneal tumors were hemodynamic instability and massive hemorrhage. Comprehensive preoperative preparation, advanced hemodynamic monitoring, proactive management of intravascular volume, and adequate availability of blood products may be critical components in improving patient outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Zitieren
APA
Zhang, X., Wei, H., He, M., Sun, X., Wang, Z., & Li, M. (2026). Perioperative anesthetic management for resection of giant retroperitoneal tumors. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1833254
Vancouver
Zhang X, Wei H, He M, Sun X, Wang Z, Li M. Perioperative anesthetic management for resection of giant retroperitoneal tumors. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1833254
BibTeX
@article{Zhang2026,
author = {Zhang, Xiaoxia and Wei, Han and He, Miao and Sun, Xiaoli and Wang, Zhenyuan and Li, Mingying},
title = {Perioperative anesthetic management for resection of giant retroperitoneal tumors},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1833254}
}
EUVIMED